BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 15864279)

  • 21. The two faces of transforming growth factor beta in carcinogenesis.
    Roberts AB; Wakefield LM
    Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8621-3. PubMed ID: 12861075
    [No Abstract]   [Full Text] [Related]  

  • 22. A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes.
    Kent OA; Mendell JT
    Oncogene; 2006 Oct; 25(46):6188-96. PubMed ID: 17028598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Genome analysis on human chromosome 14 and searching for the disease related genes].
    Isobe M
    Tanpakushitsu Kakusan Koso; 1997 Dec; 42(17 Suppl):2714-20. PubMed ID: 9455183
    [No Abstract]   [Full Text] [Related]  

  • 24. Possible involvement of RUNX3 silencing in the peritoneal metastases of gastric cancers.
    Sakakura C; Hasegawa K; Miyagawa K; Nakashima S; Yoshikawa T; Kin S; Nakase Y; Yazumi S; Yamagishi H; Okanoue T; Chiba T; Hagiwara A
    Clin Cancer Res; 2005 Sep; 11(18):6479-88. PubMed ID: 16166423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumour suppressor gene mutations in humans and mice: parallels and contrasts.
    Hooper ML
    EMBO J; 1998 Dec; 17(23):6783-9. PubMed ID: 9843483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of AML/Runx and ETO/MTG family members during hematopoietic differentiation of embryonic stem cells.
    Okumura AJ; Peterson LF; Lo MC; Zhang DE
    Exp Hematol; 2007 Jun; 35(6):978-88. PubMed ID: 17533052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluating the oncogenic risk of residual DNA in vaccines: the potential role of transgenic mice.
    Onions D
    Dev Biol (Basel); 2001; 106():135-42; discussion 143-60. PubMed ID: 11761227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RUNX: a trilogy of cancer genes.
    Lund AH; van Lohuizen M
    Cancer Cell; 2002 Apr; 1(3):213-5. PubMed ID: 12086855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RUNX3 suppresses gastric epithelial cell growth by inducing p21(WAF1/Cip1) expression in cooperation with transforming growth factor {beta}-activated SMAD.
    Chi XZ; Yang JO; Lee KY; Ito K; Sakakura C; Li QL; Kim HR; Cha EJ; Lee YH; Kaneda A; Ushijima T; Kim WJ; Ito Y; Bae SC
    Mol Cell Biol; 2005 Sep; 25(18):8097-107. PubMed ID: 16135801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ETS transcription factors and their emerging roles in human cancer.
    Seth A; Watson DK
    Eur J Cancer; 2005 Nov; 41(16):2462-78. PubMed ID: 16213704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ITF-2 is disrupted via allelic loss of chromosome 18q21, and ITF-2B expression is lost at the adenoma-carcinoma transition.
    Herbst A; Bommer GT; Kriegl L; Jung A; Behrens A; Csanadi E; Gerhard M; Bolz C; Riesenberg R; Zimmermann W; Dietmaier W; Wolf I; Brabletz T; Göke B; Kolligs FT
    Gastroenterology; 2009 Aug; 137(2):639-48, 648.e1-9. PubMed ID: 19394332
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p63: oncogene or tumor suppressor?
    Mills AA
    Curr Opin Genet Dev; 2006 Feb; 16(1):38-44. PubMed ID: 16359856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Remarkable difference of somatic mutation patterns between oncogenes and tumor suppressor genes.
    Liu H; Xing Y; Yang S; Tian D
    Oncol Rep; 2011 Dec; 26(6):1539-46. PubMed ID: 21887471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RUNX family: Regulation and diversification of roles through interacting proteins.
    Chuang LS; Ito K; Ito Y
    Int J Cancer; 2013 Mar; 132(6):1260-71. PubMed ID: 23180629
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RUNX and cancer.
    Ito Y; Osato M; Ito K
    Ann Acad Med Singap; 2003 Sep; 32(5 Suppl):S6-7. PubMed ID: 14968716
    [No Abstract]   [Full Text] [Related]  

  • 36. Intranuclear organization of RUNX transcriptional regulatory machinery in biological control of skeletogenesis and cancer.
    Stein GS; Lian JB; Stein JL; van Wijnen AJ; Montecino M; Pratap J; Choi J; Zaidi SK; Javed A; Gutierrez S; Harrington K; Shen J; Young D
    Blood Cells Mol Dis; 2003; 30(2):170-6. PubMed ID: 12732180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physical and functional interactions between STAT5 and Runx transcription factors.
    Ogawa S; Satake M; Ikuta K
    J Biochem; 2008 May; 143(5):695-709. PubMed ID: 18296717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cancer progression: is inhibin alpha from Venus or Mars?
    Ball EM; Mellor SL; Risbridger GP
    Cytokine Growth Factor Rev; 2004 Oct; 15(5):291-6. PubMed ID: 15450247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RUNX1 (AML-1) and RUNX2 (AML-3) cooperate with prostate-derived Ets factor to activate transcription from the PSA upstream regulatory region.
    Fowler M; Borazanci E; McGhee L; Pylant SW; Williams BJ; Glass J; Davis JN; Meyers S
    J Cell Biochem; 2006 Jan; 97(1):1-17. PubMed ID: 16237704
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure and Biophysics of CBFβ/RUNX and Its Translocation Products.
    Tahirov TH; Bushweller J
    Adv Exp Med Biol; 2017; 962():21-31. PubMed ID: 28299648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.